Pfizer sued Novo Nordisk, Metsera and Metsera's controlling shareholders on Oct. 31 in Delaware Court of Chancery in relation to Pfizer's proposed acquisition of Metsera, an obesity treatment maker.
Orient Pharma was hit with a patent infringement lawsuit on June 16 in Delaware District Court over its attempt to market generic versions of Pfizer's Xeljanz XR treatment for autoimmune conditions.
Key takeaways from Supreme Court arguments on Nov. 5 over the legality of the Trump administration’s reciprocal and fentanyl-linked tariffs led Bloomberg Intelligence’s Votes and Verdicts podcast this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results